Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30 <sup>+</sup> lymphoproliferative disorder: A case report-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30 ⁺ lymphoproliferative disorder: A case report

Published:2022-03-24 Issue:6 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Ceglie Giulia¹²^ORCID,De Vito Rita³,Cossutta Matilde⁴,Tiberi Alice⁴,Carta Roberto¹,Boccieri Emilia¹,Palumbo Giuseppe¹⁴

Affiliation:

1. Department of Pediatric Hematology and Oncology, Cell and Gene Therapy Bambino Gesù Children's Hospital, IRCCS Rome Italy

2. Department of Systems Medicine University of Rome Tor Vergata Rome Italy

3. Department of Pathology Bambino Gesù Children's Hospital, IRCCS Rome Italy

4. University Department of Pediatrics Bambino Gesù Children's Hospital IRCCS Rome Italy

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29626

Reference11 articles.

1. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review

2. CD30 + Lymphoproliferative Disorders of the Skin

3. EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma*

4. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas

5. Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP